Company Financials

Eagle Pharmaceuticals, Inc. Financials

United States dollar

business Eagle Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: EGRX

Market Capitalization $12.7 Million as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE 5.19
Forward PE 1.27
Price to Sales TTM $0.22
Price to Book MRQ $0.23
Enterprise to Revenue 0.44
Enterprise to EBITDA 1.84

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends 2022-12-31
Most Recent Quarter 2023-06-30
Profit Margin 4.64%
Operating Margin 15.94%
Return on Assets TTM 6.63%
Return on Equity TTM 4.88%

Income Statement

Revenue TTM $257,551,008
Revenue per Share TTM $19.68
Quarterly Revenue Growth -12.80%
Gross Profit TTM $221,674,000
EBITDA $77,502,000
Net Income to Common TTM $11,948,000
Diluted EPS TTM $0.85
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $15,354,000
Total Cash per Share MRQ $1.18
Total Debt MRQ $
Total Debt to Equity MRQ 28.75
Current Ratio MRQ 2.16
Book Value per Share MRQ $19.25

Cash Flow

Operating Cash Flow TTM $-9,318,000
Levered Free Cash Flow TTM $38,314,752

EGRX Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 12,958,200
Float Shares 10,385,031
Avg 10 Volume 132,347
Avg 30 Volume None
Shares Short 1,177,408
Short Ratio 7.01
Short % of Shares 14.08%
% Held by Insiders 12.02%
% Held by Institutions 85.73%

Stock Price Summary

Beta 0.41
Fifty Two Week Low $3.95
Fifty Two Week High $30.40
Fifty Two Week Change -561.45%
Day 50 MA $5.26
Day 200 MA $9.96

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date